Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Merck
McKesson
Boehringer Ingelheim
Harvard Business School
McKinsey
AstraZeneca

Last Updated: January 28, 2020

DrugPatentWatch Database Preview

CLINICAL TRIALS PROFILE FOR DEXTROAMPHETAMINE SULFATE

See Plans and Pricing

« Back to Dashboard

All Clinical Trials for Dextroamphetamine Sulfate

Trial ID Title Status Sponsor Phase Start Date Summary
NCT00000304 Dextroamphetamine as an Adjunct in Cocaine Treatment - 1 Completed University of Texas Phase 2 1997-08-01 The purpose of this study is to evaluate dextroamphetamine sulfate (sustained release) as an adjunct in cocaine treatment; an evaluation of the ""replacement"" strategy.
NCT00000304 Dextroamphetamine as an Adjunct in Cocaine Treatment - 1 Completed National Institute on Drug Abuse (NIDA) Phase 2 1997-08-01 The purpose of this study is to evaluate dextroamphetamine sulfate (sustained release) as an adjunct in cocaine treatment; an evaluation of the ""replacement"" strategy.
NCT00000306 Dextroamphetamine as Adjunct in Cocaine/Opiate Dependent Patients - 3 Completed University of Texas Phase 2 1994-09-01 The purpose of this study is to evaluate dextroamphetamine sulfate (sustained release) as an adjunct in concurrent cocaine and opiate dependent patients.
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for Dextroamphetamine Sulfate

Condition Name

Condition Name for Dextroamphetamine Sulfate
Intervention Trials
Cocaine-Related Disorders 2
Attention-Deficit Hyperactivity Disorder (ADHD) 1
Substance-Related Disorders 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Condition MeSH

Condition MeSH for Dextroamphetamine Sulfate
Intervention Trials
Disease 4
Cocaine-Related Disorders 2
Hyperkinesis 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Locations for Dextroamphetamine Sulfate

Trials by Country

Trials by Country for Dextroamphetamine Sulfate
Location Trials
United States 3
Austria 1
Canada 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Trials by US State

Trials by US State for Dextroamphetamine Sulfate
Location Trials
Texas 2
Nevada 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Progress for Dextroamphetamine Sulfate

Clinical Trial Phase

Clinical Trial Phase for Dextroamphetamine Sulfate
Clinical Trial Phase Trials
Phase 2 4
Phase 1/Phase 2 1
N/A 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Status

Clinical Trial Status for Dextroamphetamine Sulfate
Clinical Trial Phase Trials
Completed 3
Not yet recruiting 2
Recruiting 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Sponsors for Dextroamphetamine Sulfate

Sponsor Name

Sponsor Name for Dextroamphetamine Sulfate
Sponsor Trials
National Institute on Drug Abuse (NIDA) 2
University of Texas 2
Ironshore Pharmaceuticals and Development, Inc 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Sponsor Type

Sponsor Type for Dextroamphetamine Sulfate
Sponsor Trials
Other 6
NIH 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Merck
Dow
Baxter
AstraZeneca
Boehringer Ingelheim
Moodys

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.